We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -0.61% | 41.00 | 40.50 | 41.50 | 41.25 | 40.75 | 41.25 | 1,583,505 | 16:28:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -2.97 | 116.28M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/2/2024 10:22 | Vertiz ...yup, could be the fluffer rns for sure. | amanitaangelicus | |
22/2/2024 10:22 | Time needed to evaluate latest data? I doubt it bud. Quick as ... no Smiths trying to use the already well analysed data to tempt a seller. Probably failed. Now the convi boys are demanding their pound of flesh once more. Fear not, convis have never been an issue. Why not. Tickboo said so! | amanitaangelicus | |
22/2/2024 10:14 | And as Avacta is due an update on the value of its JV with Daewoo....Affyxell this seems pertinent.....from alextak LSE: It seems that Affyxell is recruiting not one employee but several employees.☀ | vertizeasun | |
22/2/2024 10:09 | Exactly fieldhouse....and this from gmcc on LSE: "Guess LD might remain Avacta asset at least for the time being : "21 FEBRUARY 2024 Launch Diagnostics will be moving from its current office at Ash House, Ash Road, New Ash Green, Longfield, Kent to new premises. From Monday 26th February 2024 our new office address will be: Launch Diagnostics Limited, Lakeview West, Crossways Business Park, Galleon Boulevard, Dartford, Kent DA2 6QE Please note, our telephone numbers will remain the same. In addition, the Warehouse and Technical Department will still be located at its current location, so there will be no change to our delivery/despatch address Unit 11, West Yoke Farm, Michaels Lane, Ash, New Ash Green, Sevenoaks TN15 7EP" | vertizeasun | |
22/2/2024 10:03 | The expectations of many that the new company deal maker can come up with substantial new investors in just a few weeks is wishful thinking ! I would say you are talking months and not weeks. In the mean time enough cash to go until late year end . Cutting it fine ,yes ,but not out of the ordinary. Time needed to evaluate the latest data . | fieldhouse | |
22/2/2024 09:54 | So, the share price drops to 50p. £30 million raised to take through phase 2. Uncertainty goes and dose escalation progresses well with good data from C7. Two weekly dosing progresses in the US. Worries all gone ---- Share price and company do have a paradigm shift. A lot of money in the mean time transferred to the soothsayer's QED | fieldhouse | |
22/2/2024 09:39 | Tickboo et al have left the building. I think Whitey has lost a wodge too. Only Chesh in profit now. | amanitaangelicus | |
22/2/2024 09:36 | Funny you should remember something like that today | inaminute | |
22/2/2024 09:21 | Seem to recall Tom, back in the day, valuing this thing at 25p, but agreeing that a placing around the 50p mark was possible | sandcrab2 | |
22/2/2024 09:14 | Smith clearly cant get a licensing partner. Reset convis and some new ones inbound Supported by volume today. It s a rat trap Billy, and you.ve been caught. 35p all but nailed on. Myles, Tickboo TimeLord ,we need your help! | amanitaangelicus | |
22/2/2024 08:25 | Could see 35-40p at this rate! Graph looks ugly. Come on TimeLord Smith get that tardis taken to Halfords or Orange County Choppers for an overhaul! The daleks are upon us ( convi metaphor) Hopin the Cybermen dont join the fun! | amanitaangelicus | |
22/2/2024 07:57 | Ohwhatfun ...please stop. Mkt cap is definitely high for where we are,granted. But, with a decent back wind, if the data, even anecdotally, is as good as Time Lord Smith suggests, then a successful Ph2 will make the current mkt cap look farcical. The mkt has this possibility in the mkt cap, DCFs calcs etc.So,1/ Licensing deal ...okay. Has its price but Smith has managed to persuade a decent pharma that he.s onto something2/ Convi reset ...Smith all hot air ...anecdotal data on efficacy just doesnt hold up.3/ Smith.s done such a good job, data looks so good, a T/O is accepted. Smith makes a fortune,has a seat on the company, big salary, pension, options, job s a gd un.Ps if Phase 2 fails efficacy challenge, forget the pipeline.Now, where s that fluffer rns? Where.s Myles? Too silent, way too silent.Enjoy your day. | amanitaangelicus | |
21/2/2024 17:36 | As you well know, if it hovers at mid 80’s the market turns the screw on deal day, in the morning session then discounts from there, done on a fluid price if the begging bowl is out. Thus, at this point 60-70p more likely, but still in reality a crazy market cap compared to small companies as a whole. 50p and below isn’t a crazy thought given the trend. Even then it’s a market cap of £150m plus including the added shares dilution. I don’t wish it, it’s just happens to be typical market behaviour. It’s well known that trying to get funding in recent times can result in large discounts. For the chart gurus, it’s looking grim, old floor levels have caved in. | ohwhatfun | |
21/2/2024 17:28 | Daft pi.s just sitting on their shares, blissfully unaware of the TA angles and share price moves. Convi re-set looking inevitable ...existing ii.s pished off no doubt. Drip selling perhaps. Did post likely share price drop to points - it's happening. Oh well ...where the heck is Time Lord Smith? Puffing away on a big fat Havanna thinking this is the life ... | amanitaangelicus | |
21/2/2024 16:58 | 88p close. Going to raise at 75p if they are lucky now. Given the price action I guess they are struggling to generate interest Must be very difficult when you look what is going on at FARN when they ran out of cash for their trial. | loglorry1 | |
21/2/2024 15:57 | Growing health care......share price says otherwise | kpe | |
21/2/2024 14:43 | Money moving to APH [LSE] , excellent growing health care company | blackhorse23 | |
21/2/2024 14:39 | Yes, but there are schemes you know!!!!!! | atmysignal | |
21/2/2024 13:42 | And don't come back here moaning !! Stop your bed wetting !! | fieldhouse | |
21/2/2024 13:40 | If you are not happy with your investment -- Just sell up --simple!! A salary of £444,000 would attract a tax bill of £246352 . | fieldhouse | |
21/2/2024 13:03 | What about the other new starters, on 250k plus per yearGissa job avct! | atmysignal | |
21/2/2024 12:57 | £444,000k ish year. And je sold shares during covid for a new house/ extension(?) Makes you wonder. Loadsa money ...plus share options ...swimming in it. | amanitaangelicus | |
21/2/2024 12:44 | Management are on such astronomical salaries, and I mean ASTRONOMICAL, that they don't care too much about their share price as some management actually get paid 10's of thousands per month, yes, you read that correctly, PER MONTH, clear of tax.Let that sink in.So whether the stock is 100p, 90p or 70p makes not much difference to management if you have that sort of money hitting your bank account each month. | atmysignal | |
21/2/2024 10:57 | Hi Raj ...good man. The ' reset ' point was totally missed by most here - they just dont understand convis. No chance of a normal placing on top of a convi ...most unlikely. Another convi placing on top of existing? Very likely if Time Lord Smith cant get a decent licensing deal. Think Dragons Den and ' give up'. Bound to be some pain in the licensing despite Tickboo blabbering on about non- dilutive finance. No such thing as a free lunch - never is in the City.Phase 1 basic mtd stuff. Ph2 efficacy - massive. Will be lots of anecdotal stuff- there always,always is. It.s not that this is unimportant but rather there.s no real double blind quality stuff surrounding it. There isnt ,so dont try and argue. Synairgen was a classic example or trial design issues, cohort issues during covid. USA boys saw straight through the carp and killed it. Plus, the yanks dont like non US companies. Politics everywhere in the bent USA. We just have to wait. Best outcome? Take out at 120p. Tk the money and run. Mkt cap unsustainable at its current level. The 2 sales outlet purchases, what.s dropping to the bottom line - has Smith been shafted? Let.s see.GLA. | amanitaangelicus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions